Breaking News
0

Cara Therapeutic (CARA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cara Therapeutic's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
21.16 -0.28    -1.31%
15/11 - Closed. Currency in USD ( Disclaimer )
After Hours
21.16
0.00
0.00%
16:09:32 - Real-time Data
Type: Equity
Market: United States
ISIN: US1407551092 
CUSIP: 140755109
  • Volume: 386,558
  • Bid/Ask: 20.95 / 22.50
  • Day's Range: 21.12 - 22.05
START TRADING NOW
| AD | 75% of retail investor accounts lose money when trading spread bets and CFDs with this provider
Cara Therapeutic 21.16 -0.28 -1.31%
START TRADING NOW
| AD | 75% of retail investor accounts lose money when trading spread bets and CFDs with this provider

CARA Overview

 
This is the main Cara Therapeutic stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close21.44
Day's Range21.12 - 22.05
Revenue20.91M
Open21.48
52 wk Range12.19 - 27.55
EPS - 2.39
Volume386,558
Market Cap987.73M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)559,025
P/E RatioN/A
Beta2.23
1-Year Change12.79%
Shares Outstanding46,678,977
Next Earnings DateMar 26, 2020
What is your sentiment on Cara Therapeutic?
or
Market is currently closed. Voting is open during market hours.

Cara Therapeutic News


Cara Therapeutic Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Sell Buy Strong Buy
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Buy Strong Buy
Summary Strong Sell Strong Sell Strong Sell Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Cross 30 Current
Homing Pigeon 30 Current
Engulfing Bearish 5H Current
Completed Patterns
Doji Star Bearish 1W 1 Nov 03, 2019
Homing Pigeon 15 1 Nov 15, 2019 03:30PM
Deliberation Bearish 1D 4 Nov 11, 2019

Cara Therapeutic Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 21.16 20.95 22.50 386,558 -1.31% USD 15/11  
  Stuttgart 19.460 16.518 17.106 0 0.00% EUR 15/11  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 265.76 265.78 263.01 +3.12 +1.19% 25.09M 15/11  
  Facebook 195.10 195.30 193.38 +1.95 +1.01% 11.53M 15/11  
  Alphabet A 1,333.54 1,333.54 1,311.89 +24.39 +1.86% 1.96M 15/11  
  Alphabet C 1,334.87 1,334.88 1,314.28 +23.41 +1.78% 1.78M 15/11  
  Microsoft 149.97 149.99 148.27 +1.91 +1.29% 23.51M 15/11  
  IBM 134.40 135.12 134.03 +0.40 +0.30% 3.26M 15/11  
  Danaher 142.99 143.03 138.97 +6.84 +5.02% 13.75M 15/11  
  Tesla 352.17 352.80 348.36 +2.82 +0.81% 4.81M 15/11  
  Alibaba ADR 185.49 185.60 183.71 +2.69 +1.47% 11.31M 15/11  
  hopTo 0.2480 0.2480 0.2480 -0.0010 -0.40% 1.75K 15/11  

Cara Therapeutic Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

55

Equity Type

ORD

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The Company operates through the activities related to the discovery and development of therapeutics to treat serious medical conditions, including pain and pruritus. Its product candidate pipeline includes I.V. CR845 for acute pain; I.V. CR845 for uremic pruritus; Oral CR845 for acute and chronic pain, and CR701 for neuropathic and inflammatory pain. I.V. CR845 is an injectable version of peripheral kappa opioid receptor agonist, which is intended for the treatment of acute pain in an acute care setting. CR845 has exhibited anti-pruritic, or anti-itch, potency in standard preclinical models.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Securities Investor Protection Corporation (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CARA Comments

Write your thoughts about Cara Therapeutic
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andrew Allen
Andrew Allen Nov 07, 2018 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any thoughts on this one.
John Long
John Long Nov 03, 2018 8:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What you think about CARA earning report in 3 days from now? Up or down after report?
Episcopolian OptionTrader
Episcopolian1 Jul 10, 2017 12:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Start accumulating $CARA as $GWPH will lift the entire cannabis sector
Nicky Wu
Nicky Wu Jun 30, 2017 1:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think it's going to balance out at 15 price target is at 25 now!
Episcopolian OptionTrader
Episcopolian1 Jun 30, 2017 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trail data was excellent! Don't let little bit of "profit taking" get you down!
Solid Gold
Solid Gold Apr 13, 2017 11:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good entry point here?
Chad Mann
Chad Mann Apr 09, 2017 11:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going to be good 3-6 for me
Andy White
Andy White Mar 28, 2017 11:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it seems like a rocket....
Everett Wright
Everett Wright Mar 08, 2017 9:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Earnings was good still looking for a nice gain today
Pedro Martinez Sanz
Pedro Martinez Sanz Dec 29, 2016 1:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats happend about cara ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email